These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10822046)

  • 1. Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor.
    Wood M; Chaubey M; Atkinson P; Thomas DR
    Eur J Pharmacol; 2000 May; 396(1):1-8. PubMed ID: 10822046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
    Wurch T; Colpaert FC; Pauwels PJ
    Neuropharmacology; 2003 Jun; 44(7):873-81. PubMed ID: 12726819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.
    Varrault A; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):367-74. PubMed ID: 1436121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S 14506: novel receptor coupling at 5-HT(1A) receptors.
    Milligan G; Kellett E; Dacquet C; Dubreuil V; Jacoby E; Millan MJ; Lavielle G; Spedding M
    Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit.
    Welsby PJ; Carr IC; Wilkinson G; Milligan G
    Br J Pharmacol; 2002 Oct; 137(3):345-52. PubMed ID: 12237254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.
    Zhang JY; Nawoschik S; Kowal D; Smith D; Spangler T; Ochalski R; Schechter L; Dunlop J
    Eur J Pharmacol; 2003 Jul; 472(1-2):33-8. PubMed ID: 12860470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
    Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
    Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor:effector coupling.
    Walsh M; Foley JF; Kinsella BT
    Biochim Biophys Acta; 2000 Apr; 1496(2-3):164-82. PubMed ID: 10771086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus.
    Fowler CJ; Ahlgren PC; Brännström G
    Br J Pharmacol; 1992 Sep; 107(1):141-5. PubMed ID: 1330157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
    Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
    Mørk A; Geisler A
    Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
    Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
    Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutations in the third intracellular loop of the serotonin 5-HT(1A) receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner.
    Malmberg A; Strange PG
    J Neurochem; 2000 Sep; 75(3):1283-93. PubMed ID: 10936212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.